E.H. Strisower

939 total citations
20 papers, 655 citations indexed

About

E.H. Strisower is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, E.H. Strisower has authored 20 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 6 papers in Physiology. Recurrent topics in E.H. Strisower's work include Lipoproteins and Cardiovascular Health (6 papers), Adipose Tissue and Metabolism (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). E.H. Strisower is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Adipose Tissue and Metabolism (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). E.H. Strisower collaborates with scholars based in United States. E.H. Strisower's co-authors include I.L. Chaikoff, Beverly Strisower, Gerald L. Adamson, G. L. Searle, Alex V. Nichols, Donald L. Puppione, Gertrude M. Forte, Frank T. Lindgren, D. D. Feller and John W. Gofman and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Physiological Reviews.

In The Last Decade

E.H. Strisower

20 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.H. Strisower United States 13 233 194 189 166 106 20 655
Sylvia Zottu United States 11 230 1.0× 153 0.8× 185 1.0× 163 1.0× 62 0.6× 13 594
S. S. Chernick United States 15 372 1.6× 259 1.3× 328 1.7× 234 1.4× 92 0.9× 22 957
W. Schrade Germany 13 154 0.7× 103 0.5× 118 0.6× 106 0.6× 31 0.3× 37 601
T Zemplenyi United States 14 154 0.7× 74 0.4× 105 0.6× 85 0.5× 78 0.7× 41 486
Lee A. Bricker United States 14 244 1.0× 86 0.4× 75 0.4× 179 1.1× 49 0.5× 28 560
C. Delcroix Belgium 13 189 0.8× 251 1.3× 70 0.4× 236 1.4× 61 0.6× 28 524
Merrill Overturf United States 13 234 1.0× 88 0.5× 112 0.6× 100 0.6× 31 0.3× 31 535
T. Shirotani Japan 8 316 1.4× 138 0.7× 162 0.9× 183 1.1× 54 0.5× 11 623
E.S. Morrison United States 14 196 0.8× 46 0.2× 136 0.7× 207 1.2× 35 0.3× 27 697
A M Ostlund-Lindqvist Sweden 7 165 0.7× 281 1.4× 60 0.3× 183 1.1× 102 1.0× 7 572

Countries citing papers authored by E.H. Strisower

Since Specialization
Citations

This map shows the geographic impact of E.H. Strisower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.H. Strisower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.H. Strisower more than expected).

Fields of papers citing papers by E.H. Strisower

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.H. Strisower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.H. Strisower. The network helps show where E.H. Strisower may publish in the future.

Co-authorship network of co-authors of E.H. Strisower

This figure shows the co-authorship network connecting the top 25 collaborators of E.H. Strisower. A scholar is included among the top collaborators of E.H. Strisower based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.H. Strisower. E.H. Strisower is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strisower, E.H., Gerald L. Adamson, & Beverly Strisower. (1970). Treatment of Hyperlipidemic States. Medical Clinics of North America. 54(6). 1599–1613. 15 indexed citations
2.
Puppione, Donald L., Gertrude M. Forte, Alex V. Nichols, & E.H. Strisower. (1970). Partial characterization of serum lipoproteins in the density interval 1.04–1.06 g/ml. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 202(2). 392–395. 42 indexed citations
3.
Strisower, E.H., et al.. (1968). Effect of ileal bypass on serum lipoproteins in essential hypercholesterolemia. Journal of Atherosclerosis Research. 8(3). 525–534. 17 indexed citations
4.
Strisower, E.H., Gerald L. Adamson, & Beverly Strisower. (1968). Treatment of hyperlipidemias. The American Journal of Medicine. 45(4). 488–501. 90 indexed citations
5.
Nichols, Alex V., et al.. (1968). Analysis of change in ultracentrifugal lipoprotein profiles following heparin and ethyl-p-chlorophenoxyiso-butyrate administration. Clinica Chimica Acta. 20(2). 277–283. 44 indexed citations
6.
Strisower, E.H.. (1966). The Combined Use of CPIB and Thyroxine in Treatment of Hyperlipoproteinemias. Circulation. 33(2). 291–296. 15 indexed citations
7.
Strisower, E.H. & Beverly Strisower. (1964). The Separate Hypolipoproteinemic Effects of Dextrothyroxine and Ethyl Chlorophenoxyisobutyrate. The Journal of Clinical Endocrinology & Metabolism. 24(2). 139–144. 26 indexed citations
8.
Strisower, E.H.. (1963). The response of hyperlipoproteinemias to atromid and ethyl chlorophenoxyisobutyrate. Journal of Atherosclerosis Research. 3(5-6). 445–453. 35 indexed citations
9.
Strisower, E.H., et al.. (1962). Waldenström's macroglobulinemia. The American Journal of Medicine. 32(2). 304–312. 3 indexed citations
10.
Strisower, E.H., et al.. (1959). THE EFFECT OF BETAINE ON HUMAN SERUM LIPOPROTEINS*. The Journal of Clinical Endocrinology & Metabolism. 19(7). 770–782. 1 indexed citations
11.
Strisower, E.H., et al.. (1958). Tyrosine, Iodide, and Human Serum Lipoproteins.. Experimental Biology and Medicine. 97(3). 698–700. 2 indexed citations
12.
Strisower, E.H., et al.. (1958). PHYSIOLOGIC EFFECTS OFl-TRIIODOTHYRONLNE*. The Journal of Clinical Endocrinology & Metabolism. 18(7). 721–735. 9 indexed citations
13.
Strisower, E.H., et al.. (1958). THE EFFECT OF INSULIN ON SERUM LIPOPROTEINS OF DIABETIC PATIENTS*. The Journal of Clinical Endocrinology & Metabolism. 18(12). 1418–1427. 10 indexed citations
14.
Strisower, E.H., et al.. (1957). SERUM LIPOPROTEIN CONCENTRATIONS IN A SCHIZOPHRENIC POPULATION. American Journal of Psychiatry. 114(3). 263–265. 5 indexed citations
15.
Strisower, E.H., et al.. (1957). Conversion of Fatty Acids to Carbohydrate: Application of Isotopes to this Problem and Role of the Krebs Cycle as a Synthetic Pathway. Physiological Reviews. 37(2). 252–272. 154 indexed citations
16.
Searle, G. L., E.H. Strisower, & I.L. Chaikoff. (1956). Determination of Rates of Glucose Oxidation in Normal and Diabetic Dogs by a Technique Involving Continuous Injection of C14-Glucose. American Journal of Physiology-Legacy Content. 185(3). 589–594. 25 indexed citations
17.
Searle, G. L., E.H. Strisower, & I.L. Chaikoff. (1954). Glucose Pool and Glucose Space in the Normal and Diabetic Dog. American Journal of Physiology-Legacy Content. 176(2). 190–194. 50 indexed citations
18.
Strisower, E.H., et al.. (1952). INCORPORATION OF ACETATE CARBON INTO GLUCOSE BY LIVER SLICES FROM NORMAL AND ALLOXAN-DIABETIC RATS. Journal of Biological Chemistry. 198(1). 115–126. 66 indexed citations
19.
Strisower, E.H., et al.. (1951). CONVERSION OF C14-PALMITIC ACID TO GLUCOSE. Journal of Biological Chemistry. 192(2). 453–463. 11 indexed citations
20.
Feller, D. D., I.L. Chaikoff, E.H. Strisower, & G. L. Searle. (1951). GLUCOSE UTILIZATION IN THE DIABETIC DOG, STUDIED WITH C14-GLUCOSE. Journal of Biological Chemistry. 188(2). 865–880. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026